Accounts Payable and Accrued Liabilities |
8. Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities consist of the following (in thousands): | | | | | | | | | | | | | As of | | September 30, 2024 | | December 31, 2023 | Accounts payable and other accrued operating expenses | $ | 64,950 | | | $ | 65,393 | | Accrued clinical trial expenses | 19,456 | | | 23,711 | | Accrued professional fees | 19,627 | | | 13,885 | | Accrued technical operation expenses | 8,953 | | | 9,187 | | | | | | Accrued compensation and employee related costs | 55,698 | | | 48,933 | | Accrued royalty and milestones payable | 6,639 | | | 5,674 | | Accrued interest payable | 1,437 | | | 2,175 | | Revenue Interest Payments payable | 3,723 | | | 3,347 | | Accrued sales allowances and related costs | 14,458 | | | 10,937 | | Accrued France ATU reimbursement payable | 19,117 | | | 14,685 | | Deferred and contingent consideration | 26,100 | | | 6,700 | | | | | | | | | | Other accrued liabilities | 8,526 | | | 10,360 | | | $ | 248,684 | | | $ | 214,987 | |
|